Title : Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments - Hoang_2022_Trials_23_623 |
Author(s) : Hoang K , Watt H , Golemme M , Perry RJ , Ritchie C , Wilson D , Pickett J , Fox C , Howard R , Malhotra PA |
Ref : Trials , 23 :623 , 2022 |
Abstract : Hoang_2022_Trials_23_623 |
ESTHER : Hoang_2022_Trials_23_623 |
PubMedSearch : Hoang_2022_Trials_23_623 |
PubMedID: 35915506 |
Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, Pickett J, Fox C, Howard R, Malhotra PA (2022)
Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments
Trials
23 :623
Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, Pickett J, Fox C, Howard R, Malhotra PA (2022)
Trials
23 :623